Novartis delivered solid sales growth, margin expansion and pipeline progress in 2014, according to a January 27 news release which also indicated portfolio transformation will focus the company on leading business.
Net sales and operating income both increased by 1% in 2014 to USD 58 billion and USD 10.7 billion respectively. Net income grew by 12% to USD 10.3 billion.
Growth products and Emerging Growth Markets continued to drive performance in 2014 Q4 with an increase of 14% to USD 4.7 billion, or 32% of Group net sales. Novartis also saw continued progress in transforming portfolio and increasing productivity with its divestment of Animal Health Division to Eli Lilly and Company, which completed on January 1, 2015.
Showing posts with label financial report. Show all posts
Showing posts with label financial report. Show all posts
28 January 2015
28 April 2014
Bayer releases 2014 Q1 Financial Report
Bayer released its first quarter financial report this week and the pharmaceutical company is reporting encouraging growth in its sales and earnings.
Gross cash flow in the first quarter of 2014 rose by 13.3% to €2,048 million due to the improvement in EBITDA. Net cash flow, however, declined to €163 million because more cash was tied up in working capital.
Net financial debt rose from €6.7 billion on December 31, 2013, to €9.1 billion on March 31, 2014. This increase was driven by the acquisition of Algeta ASA, Norway.
Sales of the Animal Health Division rose by 8.0% to €330 million. Business with our Advantage™ line of flea, tick and worm control products developed particularly well.
Gross cash flow in the first quarter of 2014 rose by 13.3% to €2,048 million due to the improvement in EBITDA. Net cash flow, however, declined to €163 million because more cash was tied up in working capital.
Net financial debt rose from €6.7 billion on December 31, 2013, to €9.1 billion on March 31, 2014. This increase was driven by the acquisition of Algeta ASA, Norway.
Sales of the Animal Health Division rose by 8.0% to €330 million. Business with our Advantage™ line of flea, tick and worm control products developed particularly well.
14 October 2013
PetSmart announces 18% increase to quarterly dividend and new $535 million share purchase authorization
PetSmart announced the Board of Directors' approval to increase its quarterly dividend by 18% from $0.165 to $0.195 per share beginning in the third quarter of fiscal 2013. The dividend of $0.195 will be paid on 15 November 2013 to stockholders of record at the close of business on 1 November 2013. This is equivalent to an annual rate of $0.78 per share.
The Board of Directors also authorized a new $535 million share purchase authorization that expires on 31 January 2015. This new share purchase authorization will commence 1 October 2013 and will be in addition to any unused amount remaining under the June 2012 share purchase authorization as of that date.
"We believe the stability and predictability of our cash flow demonstrates the continued strength of our business," said David Lenhardt, CEO. "And today's announcement reaffirms our commitment to returning excess cash to our shareholders though a combination of dividends and share repurchases."
The Board of Directors also authorized a new $535 million share purchase authorization that expires on 31 January 2015. This new share purchase authorization will commence 1 October 2013 and will be in addition to any unused amount remaining under the June 2012 share purchase authorization as of that date.
"We believe the stability and predictability of our cash flow demonstrates the continued strength of our business," said David Lenhardt, CEO. "And today's announcement reaffirms our commitment to returning excess cash to our shareholders though a combination of dividends and share repurchases."
07 August 2013
RSA Canada reports strong growth at half year
Royal Sun Alliance (Pets Plus Us) reported another strong financial result with 15% growth in net written premiums to $1,360 million compared to $1,181 million in the first half of 2012.
Commercial lines premiums were up 14% to $468 million with all lines of business contributing. Excluding the acquisition of UC, the Commercial portfolio grew 5% with particularly strong results within Global Specialty Lines.
Personal lines premiums, including Johnson Inc. were up 16% to $892 million, driven by the benefits of the acquisition of UC. Growth was 5% excluding UC, with a strong contribution from the Broker business, particularly in British Columbia and improved retention across the book.
The underwriting result of $23 million was inevitably impacted by severe weather, namely late June's flooding in Southern Alberta, which is exected to be one of the largest natural catastrophes in Canadian history. Gross claims in respect of this event are above reinsurance retentions, leading to a maximum net loss of $75 million. As a result, the COR was 98.7%. Excluding the impact of the Alberta floods, the COR was 93.3%.
Commercial lines premiums were up 14% to $468 million with all lines of business contributing. Excluding the acquisition of UC, the Commercial portfolio grew 5% with particularly strong results within Global Specialty Lines.
Personal lines premiums, including Johnson Inc. were up 16% to $892 million, driven by the benefits of the acquisition of UC. Growth was 5% excluding UC, with a strong contribution from the Broker business, particularly in British Columbia and improved retention across the book.
The underwriting result of $23 million was inevitably impacted by severe weather, namely late June's flooding in Southern Alberta, which is exected to be one of the largest natural catastrophes in Canadian history. Gross claims in respect of this event are above reinsurance retentions, leading to a maximum net loss of $75 million. As a result, the COR was 98.7%. Excluding the impact of the Alberta floods, the COR was 93.3%.
26 January 2013
P&G delivers second quarter fiscal results
The Proctor and Gamble Company reported increased core earnings for its fiscal year's second quarter of 2012 (October to December). Earnings per share increased by 12% to $1.22 and diluted net earnings per share increased 144% to $1.39.
Net sales were $22.2 billion, an increase of 2% versus the same quarter in 2011. The company delivered broad-based organic sales growth of 3%, with all business segments increasing organic sales by 2% or more versus the previous year.
"Our second quarter results were at the high end of our expectations on the top-line and well ahead of forecast on operating profit, earnings per share and cash flow," said chairman, president and CEO Bob McDonald. "Global market share trends improved as we continued to implement our growth strategy and make very good progress against our productivity and cost savings goals."
Net sales were $22.2 billion, an increase of 2% versus the same quarter in 2011. The company delivered broad-based organic sales growth of 3%, with all business segments increasing organic sales by 2% or more versus the previous year.
"Our second quarter results were at the high end of our expectations on the top-line and well ahead of forecast on operating profit, earnings per share and cash flow," said chairman, president and CEO Bob McDonald. "Global market share trends improved as we continued to implement our growth strategy and make very good progress against our productivity and cost savings goals."
25 May 2012
PetSmart has a 'Howler' of a first quarter
PetSmart beats earning expectations and posted a 7.4% rise in same-store sales. PetSmart had good performance from all three merchandising categories - consumables, hard goods and live goods and also from services. PetSmart is likely to see continued performance as the economy slowly improves and consumers increase spending on pet related goods and services.
Access the entire report
Access the entire report
Subscribe to:
Posts (Atom)